Cancer Clinical Trials in Detroit, Michigan

4 studies are recruiting for cancer in Detroit, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Connect for Cancer Prevention Study (Connect)

    Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of pe…

    Stage
    Not phased
    Ages
    30 to 70
    Site
    Henry Ford Health Systems, Detroit, Michigan
    Locations
    10 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT04609072 on ClinicalTrials.gov

  2. Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

    This is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at one 1 or more dosi…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Karmanos Cancer Institute, Detroit, Michigan
    Locations
    17 in total
    Run by
    MBrace Therapeutics

    See if you can join NCT06014658 on ClinicalTrials.gov

  3. Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

    The goal of this screening study is to determine the feasibility of completing a social needs screening tool in participants who have a past or current cancer diagnosis and reside in Metro Detroit, Michigan. Main questions to answer are: * Can we have a completion rate of at least 80% of participan…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Karmanos Cancer Institute, Detroit, Michigan
    Run by
    Barbara Ann Karmanos Cancer Institute

    See if you can join NCT06908629 on ClinicalTrials.gov

  4. A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

    KB707-01 is a Phase 1/2, open-label, multicenter, dose escalation and expansion study. The study will evaluate the safety and tolerability of KB707 in adults with locally advanced or metastatic solid tumors who have progressed on standard of care therapy, cannot tolerate standard of care therapy, r…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Henry Ford Cancer Institute, Detroit, Michigan
    Locations
    15 in total
    Run by
    Krystal Biotech, Inc.

    See if you can join NCT05970497 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.